Topics

Mixed Early Phase III Results With Aldeyra’s First-In-Class Dry Eye Candidate

05:56 EST 4 Dec 2019 | SCRIP

The first part of Aldeyra’s Phase III RENEW study of the aldehyde trap candidate, reproxalap, shows positive effects on one...

      

Related Stories

 

Original Article: Mixed Early Phase III Results With Aldeyra’s First-In-Class Dry Eye Candidate

NEXT ARTICLE

More From BioPortfolio on "Mixed Early Phase III Results With Aldeyra’s First-In-Class Dry Eye Candidate"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...